Guidelines and Consensus Statements

The guidelines and consensus documents below are those in which an ANZSPED member was involved in the working group that developed the guidelines.  If you are aware of others not listed below, please send through to the ANZSPED secretariat.

There are many other guidelines and consensus statements available from other countries and regions.  You can find a summary of many of these HERE or they are linked under the specific topic in the menu to the left of the screen.

Last comprehensive update completed on 16 June 2021

Dynamic Endocrine Testing

• Harmonisation of Endocrine Dynamic Testing – Paediatrics (HEDT-Paeds) 2025
• Harmonisation of Endocrine Dynamic Testing – Adult (HEDTA) (2021)

Bone & Calcium Metabolism

• Zoledronic Acid Administration – Paediatric Drug Protocol
  Developed by the APEG Bone and Mineral Working Group, June 2019
• Global Consensus Nutritonal Rickets
  Hormone Research in Paediatrics, January 2016
• APEG Position Statement: The Use of Bisphosphonate therapy for osteoporosis in children and adolescents
  March 2018

Diabetes Type 1

• 2025, Use of CGMS for Children and Adolescents with T1D at school and preschool
  Developed by the ANZSPED Diabetes Subcommittee, January 2025
• 2024 Consensus Guidance for Monitoring Individuals With Islet Autoantibody–Positive Pre-Stage 3 Type 1 Diabetes
  Published Diabetes Care 2024;47(8):1-23
• 2024 Care pathways for people with early-stage type 1 diabetes in Australia
  Jenny Couper, K Bell, Tony Huynh, M So, J Wenthworth on behalf of ATIC
• 2023 International Guidelines for the Diagnosis and Management of Hyperinsulinism
  Diva D. De Leon; Jean Baptiste Arnoux;Indraneel Banerjee; Ignacio Bergada; Tricia Bhatti; Louise S. Conwell; Junfen Fu; Sarah E. Flanagan; David Gillis; Thomas Meissner; Klaus Mohnike; Tai L.S. Pasquini; Pratik Shah; Charles A. Stanley; Adrian Vella; Tohru Yorifuji; Paul S. Thornton
• 2022 Qld Disordered Eating Guidelines
  March 2022
• 2021 ADS/ADEA/APEG/ADIPS - Utilisation, access and recommendations regarding technologies for people living with type 1 diabetes (file)
  Authors: Anthony J Pease, Sofianos Andrikopoulos, Mary B Abraham, Maria E Craig, Brett Fenton, Jane Overland, Sarah price, David Simmons and Glynis P Ross
• 2021 Australian National Diabetes Strategy 2021-2030
  August 2021
• 2021: Utilisation, access, and recommendations regarding technologies for people living with type 1 diabetes (link)
  Anthony J Pease, Sofianos Andrikopoulos, Mary B Abraham, Maria E Craig, Brett Fenton, Jane Overland, Sarah Price, David Simmons and Glynis P Ross
• 2020, Screening, assessment and management of type 2 diabetes mellitus in children and adolescents: Australia and New Zealand Society for Paediatric Endocrinology and Diabetes guidelines
  Med J Aust 2020; 213 (1), July 2020
• 2020, Australian Living Evidence-Based Clinical Guidelines for Diabetes
  Published 27 November 2020

Diabetes Type 2

• Screening, assessment and management of type 2 diabetes mellitus in children and adolescents: Australasia Paediatric Endocrine Group guidelines
  Australasia Paediatric Endocrine Group
• 2022 Management of type 2 diabetes in young adults aged 18–30 years: ADS/ADEA/APEG consensus statement
  April 2022

Glucose and Pancreas Disorders (Non Diabetes)

• 2024 International Guidelines for the Diagnosis and Management of Hyperinsulinism
  Horm Res Paediatr (2024) 97 (3): 279–298. Louise Conwell et al

Neonatal Endocrinology

• Birthweight or Gestational Age Adjusted Second Tier LCMSMS Cut-offs Improve Newborn Screening for CAH in New Zealand
  Mark R de Hora, MSc, Natasha L Heather, MD, Dianne Webster, PhD, Benjamin B Albert, MBChB, Paul L Hofman, MBChB
• Initial management and stabilisation of the newborn infant with a positive screen for congenital adrenal hyperplasia (CAH): An ANZSPED guideline.
  One page Guide. ANZSPED Lab and NBS Subcommittee, March 2025
• Initial management and stabilisation of the newborn infant with a positive screen for congenital adrenal hyperplasia (CAH): An ANZSPED guideline.
  Detailed Guide. ANZSPED Lab and NBS Subcommittee, March 2025

Polycystic Ovary Syndrome

• The Diagnosis of Polycystic Ovary Syndrome during Adolescence
  Hormone Research in Paediatrics, July 2015
• An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence
  Horm Res Paediatr. 2017 Nov 13;Vol.(6):307-331. doi: 10.1159/000479371. [Epub ahead of print] PMID: 29156452 [PubMed – as supplied by publisher] Free Article Similar articles
• International evidence-based guideines for the assessment and management of polycystic ovary syndrome 2023
  Collaboration led by Monash University 2023

Sex Development

• Global Disorders of Sex Development Update since 2006: Perceptions, Approach and Care
  Hormone Research in Paediatrics, January 2016
• APEG Position Statement on the Clinical Care of Children with DSD V1.1
  DSD Subcommittee, June 2022
• Clinical Practice Guidelines for the Care of Girls and Women with Turner Syndrome
  Published May 2024

Syndromes & Genetic Tests

• The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline.
  JCEM Oct 2016

Thyroid

• European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism.
  Congenital Hypothyroidism Consensus Conference Group. Hormone research in paediatrics. 81(2):80-103, 2014
• Guidelines for Management of Congenital Hypothyroidism
  Developed 2007

Weight Disorders / Obesity

• Obesity Clinical Practice Guideline (article)
  Endocrine News Article, February 2017 (re March 2017 JCEM publication)
• Clinical Practice Guidelines for the Evaluation and Treatment of Children and Adolescents with Obesity
  American Academy of Pediatrics (Janauary 2023)